FDA-Drug2018-12-26Class II
Nevirapine Extended Release Tablets, 400 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd. Verna Goa, India, Manufactured for: Cipla USA Inc. 9100 S Dadeland Blvd., Suite 1500 Miami, FL 33156, NDC 69097-403-02
Cipla Limited
Hazard
Failed Dissolution Specifications.
Sold states
Nationwide within the United States
Affected count
4800 bottles
Manufactured in
L129 - 146 S - 103 - 105 S - 107 - 112 L147 - L147/1/2/3 L147/A, Vasco Da Gama, India
Products
Nevirapine Extended Release Tablets, 400 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd. Verna Goa, India, Manufactured for: Cipla USA Inc. 9100 S Dadeland Blvd., Suite 1500 Miami, FL 33156, NDC 69097-403-02
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0382-2019Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief